Followers | 2429 |
Posts | 91421 |
Boards Moderated | 5 |
Alias Born | 09/12/2003 |
![](https://investorshub.advfn.com/uicon/26252.png?cb=1665110536)
Thursday, December 10, 2020 5:50:57 PM
Recent ADTX News
- Biotech Soars Despite Broader Selloff • AllPennyStocks.com • 08/07/2024 07:25:00 PM
- Aditxt Subsidiary Pearsanta Seeks Clinical Trial Translational Endpoints Research Award for Early Detection of Ovarian Cancer • Business Wire • 08/07/2024 12:15:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/07/2024 04:15:16 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/01/2024 08:15:15 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/01/2024 08:15:13 PM
- Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1st • GlobeNewswire Inc. • 07/25/2024 01:00:00 PM
- Aditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the Acquisition • Business Wire • 07/25/2024 12:30:00 PM
- Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1 • PR Newswire (US) • 07/23/2024 12:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 08:15:08 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 07/18/2024 08:17:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 08:15:24 PM
- Aditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 Closing • Business Wire • 07/17/2024 10:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/11/2024 08:30:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 09:09:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 10:25:49 AM
- Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare • PR Newswire (US) • 06/27/2024 12:36:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/14/2024 08:01:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:35:45 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 06/07/2024 09:12:12 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/29/2024 08:33:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 10:08:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:24:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:15:45 PM
- Evofem Biosciences Announces Financial Results for the First Quarter of 2024 • PR Newswire (US) • 05/15/2024 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:15:21 PM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM